Inovio Pharmaceuticals, Inc. (INO)
NASDAQ·Healthcare·Biotechnology
$1.46
-10.19%
Mkt Cap $41.62M
Analyst Ratings
Buy
3
Hold
1
Sell
0
Price Target (7 analysts)
$2.75
Range $2.50 – $3.00
Implied Upside
+89.0%
Consensus $2.75 vs current $1.46
NASDAQ·Healthcare·Biotechnology
$1.46
-10.19%
Mkt Cap $41.62M
Buy
3
Hold
1
Sell
0
Price Target (7 analysts)
$2.75
Range $2.50 – $3.00
+89.0%
Consensus $2.75 vs current $1.46